Detection of papillomavirus DNA in the prostate: A virus with underestimated clinical relevance?;Die detektion von papillomavirus-DNA in der prostata: Ein virus mit unterschätzter klinischer relevanz?

Urologe - Ausgabe A

Volumn 47, Issue 7, 2008, Pages 846-852

  May, M ^a   Kalisch, R ^b   Hoschke, B ^a   Juretzek, T ^b   Wagenlehner, F ^c   Brookman Amissah, S ^a   Spivak, I ^b   Braun, K P ^a   Bar W ^b   Helke, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CARL THIEM KLINIKUM   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

HPV; Human papillomavirus; Prostate; Prostate cancer; Real time PCR

Indexed keywords

BACTERIAL DNA; FUNGAL DNA; VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; GENOTYPE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

AGED; COMORBIDITY; DNA, BACTERIAL; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 46949083631     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-008-1694-5     Document Type: Article

References (38)

1. Penson DF, Chan JM, Urologic Diseases in America Project (2007) Prostate cancer. J Urol 177: 2020-2029
2. Nam RK, Toi A, Klotz LH et al. (2007) Assessing individual risk for prostate cancer. J Clin Oncol 25: 3582-3588
3. Nelen V (2007) Epidemiology of prostate cancer. Recent Results Cancer Res 175: 1-8
4. Ravich A, Ravich RA (1950) Prophylaxis of cancer of the prostate, penis, and cervix by circumcision. NY State J Med 50: 1519-1520
5. Al-Maghrabi JA (2007) The role of human papillomavirus infection in prostate cancer. Saudi Med J 28: 326-333
6. Sutcliffe S, Giovannucci E, Gaydos CA et al. (2007) Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 16: 1573-1580
7. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350
8. Sawaya GF, Smith-McCune K (2007) HPV vaccination - more answers, more questions. N Engl J Med 356: 19991-19993
9. Zambrano A, Kalantari M, Simoneau A et al. (2002) Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53: 263-276
10. Choo CK, Ling MT, Chan KW et al. (1999) Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate 40: 150-158
11. Taylor ML, Mainous AG 3rd, Wells BJ (2005) Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 37: 506-512
12. McNicol PJ, Dodd JG (1990) Detection of papillomavirus DNA in human prostatic tissue by Southern blot analysis. Can J Microbiol 36: 359-362
13. McNicol PJ, Dodd JG (1990) Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol 28: 409-412
14. Masood S, Rhatigan RM, Powell S et al. (1991) Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J 84: 235-236
15. McNicol PJ, Dodd JG (1991) High prevalence of human papillomavirus in prostate tissues. J Urol 145: 850-853
16. Anwar K, Nakakuki K, Shiraishi T et al. (1992) Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52: 5991-5996
17. Serfling U, Ciancio G, Zhu WY et al. (1992) Human papillomavirus and herpes virus DNA are not detected in benign and malignant prostatic tissue using the polymerase chain reaction. J Urol 148: 192-194
18. Ibrahim GK, Gravitt PE, Dittrich KL et al. (1992) Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 148: 1822-1826
19. Dodd JG, Paraskevas M, McNicol PJ (1993) Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol 149: 400-402
20. Moyret-Lalle C, Marcais C, Jacquemier J et al. (1995) ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 64: 124-129
21. Wideroff L, Schottenfeld D, Carey TE et al. (1996) Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 28: 117-123
22. Dillner J, Knekt P, Boman J et al. (1998) Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 75: 564-567
23. Noda T, Sasagawa T, Dong Y et al. (1998) Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 26: 165-169
24. Strickler HD, Burk R, Shah K et al. (1998) A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 82: 1118-1125
25. Serth J, Panitz F, Paeslack U et al. (1999) Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 59: 823-825
26. Hayes RB, Pottern LM, Strickler H et al. (2000) Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 82: 718-725
27. Hisada M, Rabkin CS, Strickler HD et al. (2000) Human papillomavirus antibody and risk of prostate cancer. JAMA 283: 340-341
28. Adami HO, Kuper H, Andersson SO et al. (2003) Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 12: 872-875
29. Rosenblatt KA, Carter JJ, Iwasaki LM et al. (2003) Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 12: 763-768
30. Carozzi F, Lombardi FC, Zendron P et al. (2004) Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 19: 257-261
31. Leiros GJ, Galliano SR, Sember ME et al. (2005) Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 5: 15
32. Korodi Z, Dillner J, Jellum E et al. (2005) Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 14: 2952-2955
33. Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102: 3-8
34. Ledger WJ, Jeremias J, Witkin SS (2000) Testing for high-risk human papillomavirus types will become a standard of clinical care. Am J Obstet Gynecol 182: 860-865
35. Hochreiter WW, Duncan JL, Schaeffer AJ (2000) Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol 163: 127-130
36. Tang S, Tao M, McCoy JP Jr, Zheng ZM (2006) The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249-4263
37. Das D, Shah RB, Imperiale MJ (2004) Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23: 7031-7046
38. McCabe MT, Low JA, Imperiale MJ, Day ML (2006) Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway. Oncogene 25: 2727-2735